Unknown PHASE1 INTERVENTIONAL 3-arm NCT02452489

Different Acupoints Compatibility Difference of the Effect of Treatment of the Diabetic Gastroparesis

Scheme Optimization of Acupoints Compatibility and Influence Factors of the Effect

Sponsor: Changchun University of Chinese Medicine

Interventions acupuncture

Updated 7 times since 2017 Last updated: May 21, 2015 Started: Jan 31, 2015 Primary completion: Dec 31, 2017 Completion: Aug 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Diabetic Gastroparesis, this trial is ongoing. The trial is conducted by Changchun University of Chinese Medicine and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Sep 2018 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Jun 2018 — Sep 2018 [monthly]

Recruiting PHASE1

▶ Show 2 earlier versions

Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE1
Jan 2017 — Jun 2017 [monthly]

Recruiting PHASE1

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changchun University of Chinese Medicine
Hengyang Traditional Chinese Medicine Hospital
Jilin University
Qilu Hospital of Shandong University
Second People's Hospital of Hunan
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

Data source: Changchun University of Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Changchun, China